Ionis Pharmaceuticals Inc
NASDAQ:IONS 11:39:28 AM EDT
| Market Cap (Intraday) | 7.32B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $55.77 |
| 50-Day MA | $58.25 |
| 200-Day MA | $54.62 |
Ionis Pharmaceuticals, Inc. Stock, NASDAQ:IONS
2855 Gazelle Court, Carlsbad, California 92010
United States of America
Phone: +1.760.931.9200
Number of Employees: 817
Description
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The Akcea Therapeutics segment develops and commercializes drugs for cardiometabolic diseases. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA.